MeSH term
Frequency | Condition_Probility | Humans | 26 | 0.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Alleles | 6 | 0.0 |
Animals | 4 | 0.0 |
Bipolar Disorder/*genetics | 2 | 1.0 |
Cell Line | 2 | 0.0 |
Female | 18 | 0.0 |
Gene Frequency | 8 | 0.0 |
Male | 19 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
Rats | 2 | 0.0 |
Receptor, Serotonin, 5-HT2C | 11 | 55.0 |
Receptors, Serotonin/*genetics | 9 | 12.0 |
Research Support, Non-U.S. Gov't | 19 | 0.0 |
Adult | 14 | 0.0 |
Pharmacogenetics | 2 | 1.0 |
Comparative Study | 5 | 0.0 |
Cysteine | 2 | 1.0 |
Depressive Disorder/*genetics | 2 | 10.0 |
Ethnic Groups | 2 | 0.0 |
Europe/ethnology | 2 | 2.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Israel | 3 | 1.0 |
Linkage (Genetics) | 3 | 0.0 |
*Polymorphism, Genetic | 6 | 0.0 |
Reference Values | 2 | 0.0 |
Serine | 2 | 2.0 |
*Variation (Genetics) | 2 | 0.0 |
Adolescent | 5 | 0.0 |
DNA/blood | 2 | 1.0 |
DNA Primers/genetics | 2 | 0.0 |
Genotype | 12 | 0.0 |
Middle Aged | 6 | 0.0 |
Receptor, Serotonin, 5-HT2C/*genetics | 3 | 75.0 |
Risk Factors | 2 | 0.0 |
Membrane Glycoproteins/genetics | 5 | 2.0 |
Membrane Transport Proteins/genetics | 2 | 6.0 |
Monoamine Oxidase/genetics | 3 | 13.0 |
Nerve Tissue Proteins/genetics | 2 | 0.0 |
Questionnaires | 2 | 0.0 |
Receptor, Serotonin, 5-HT2C/genetics | 2 | 66.0 |
Serotonin/*metabolism | 3 | 6.0 |
Tryptophan Hydroxylase/genetics | 5 | 35.0 |
Carrier Proteins/genetics | 3 | 0.0 |
Jews/*genetics | 2 | 1.0 |
*Membrane Transport Proteins | 4 | 0.0 |
*Nerve Tissue Proteins | 4 | 0.0 |
Polymorphism, Genetic/*genetics | 4 | 0.0 |
Alcoholism/genetics | 2 | 8.0 |
Brain/metabolism | 2 | 0.0 |
Psychiatric Status Rating Scales | 2 | 0.0 |
Dopamine/*metabolism | 2 | 1.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Receptor, Serotonin, 5-HT2A | 3 | 7.0 |
Receptors, Dopamine D2/genetics | 3 | 6.0 |
Receptors, Serotonin/genetics | 4 | 21.0 |
Chromosome Mapping | 3 | 0.0 |
Variation (Genetics) | 4 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Haplotypes | 5 | 0.0 |
Receptors, Dopamine D2/*genetics | 2 | 0.0 |
Reward | 2 | 5.0 |
Linkage Disequilibrium | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Base Sequence | 2 | 0.0 |
Mutation | 2 | 0.0 |
*RNA Editing | 2 | 4.0 |
Genetic Markers | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
